Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?
作者信息
Caocci Giovanni, La Nasa Giorgio
机构信息
Ematologia e CTMO, Ospedale Businco Azienda Ospedaliera Brotzu, Dipartimento di Scienze Mediche e Sanità Pubblica, Università di Cagliari, Via Jenner, sn, 09124, Cagliari, Italy.
出版信息
Ann Hematol. 2020 Jul;99(7):1675-1676. doi: 10.1007/s00277-020-04067-6. Epub 2020 May 14.
Abstract
摘要
相似文献
1
Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?芦可替尼对有急性呼吸窘迫综合征（ARDS）风险的新型冠状病毒肺炎（COVID-19）感染患者是否有效？
Ann Hematol. 2020 Jul;99(7):1675-1676. doi: 10.1007/s00277-020-04067-6. Epub 2020 May 14.
2
Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?用烯丙哌三嗪治疗低氧血症型新冠肺炎“急性呼吸窘迫综合征”患者：越早越好？
Anaesth Crit Care Pain Med. 2020 Aug;39(4):451-452. doi: 10.1016/j.accpm.2020.07.003. Epub 2020 Jul 9.
3
Ruxolitinib for the treatment of SARS-CoV-2 induced acute respiratory distress syndrome (ARDS).芦可替尼用于治疗新型冠状病毒肺炎引发的急性呼吸窘迫综合征（ARDS）。
Leukemia. 2020 Aug;34(8):2276-2278. doi: 10.1038/s41375-020-0907-9. Epub 2020 Jun 17.
4
COVID-19-related Acute Respiratory Distress Syndrome: Not So Atypical.新型冠状病毒肺炎相关急性呼吸窘迫综合征：并非那么不典型。
Am J Respir Crit Care Med. 2020 Aug 15;202(4):622-624. doi: 10.1164/rccm.202004-1423LE.
5
Successful management of SARS-CoV-2 acute respiratory distress syndrome and newly diagnosed acute lymphoblastic leukemia.成功治疗 SARS-CoV-2 急性呼吸窘迫综合征和新发急性淋巴细胞白血病。
Blood Adv. 2020 Sep 22;4(18):4358-4361. doi: 10.1182/bloodadvances.2020002745.
6
Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension?螺内酯能否用于预防高血压患者的新型冠状病毒肺炎诱导的急性呼吸窘迫综合征？
Am J Physiol Endocrinol Metab. 2020 May 1;318(5):E587-E588. doi: 10.1152/ajpendo.00136.2020.
7
[Therapy of coronavirus disease 2019 induced acute respiratory distress syndrome is different from traditional acute respiratory distress syndrome].2019冠状病毒病所致急性呼吸窘迫综合征的治疗不同于传统急性呼吸窘迫综合征
Zhonghua Shao Shang Za Zhi. 2020 May 20;36(5):330-333. doi: 10.3760/cma.j.cn501120-20200407-00214.
8
Attenuated Novel SARS Coronavirus 2 Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient on Ruxolitinib.芦可替尼治疗的异基因造血干细胞移植患者中新型 SARS-CoV-2 感染减弱。
Clin Lymphoma Myeloma Leuk. 2020 Nov;20(11):720-723. doi: 10.1016/j.clml.2020.06.014. Epub 2020 Jun 25.
9
The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).在严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫情期间使用Janus激酶抑制剂。
J Am Acad Dermatol. 2020 Jun;82(6):e223-e226. doi: 10.1016/j.jaad.2020.03.099. Epub 2020 Apr 9.
10
The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19.芦可替尼通过 JAK/STAT 通路抑制在 COVID-19 治疗中的潜力。
Cytokine Growth Factor Rev. 2020 Aug;54:51-62. doi: 10.1016/j.cytogfr.2020.06.013. Epub 2020 Jun 20.
引用本文的文献
1
An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19).白细胞介素 6 信号阻断在严重 2019 年冠状病毒病（COVID-19）中的最新进展、挑战和临床考虑的更新概述。
Int Immunopharmacol. 2022 Apr;105:108536. doi: 10.1016/j.intimp.2022.108536. Epub 2022 Jan 11.
2
Carfilzomib Enhances the Suppressive Effect of Ruxolitinib in Myelofibrosis.卡非佐米增强芦可替尼在骨髓纤维化中的抑制作用。
Cancers (Basel). 2021 Sep 28;13(19):4863. doi: 10.3390/cancers13194863.
3
Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis.芦可替尼不会损害骨髓纤维化患者对BNT162b2 mRNA新冠疫苗接种的体液免疫反应。
Ann Hematol. 2022 Apr;101(4):929-931. doi: 10.1007/s00277-021-04613-w. Epub 2021 Jul 24.
4
The signal pathways and treatment of cytokine storm in COVID-19.新型冠状病毒肺炎中细胞因子风暴的信号通路与治疗策略。
Signal Transduct Target Ther. 2021 Jul 7;6(1):255. doi: 10.1038/s41392-021-00679-0.
5
TextEssence: A Tool for Interactive Analysis of Semantic Shifts Between Corpora.文本精粹：一种用于语料库间语义转移交互式分析的工具。
Proc Conf. 2021 Jun;2021:106-115.
6
Reviews on Biological Activity, Clinical Trial and Synthesis Progress of Small Molecules for the Treatment of COVID-19.综述 COVID-19 小分子治疗药物的生物活性、临床试验和合成进展
Top Curr Chem (Cham). 2021 Jan 11;379(1):4. doi: 10.1007/s41061-020-00318-2.
7
Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19.新冠病毒治疗和诊断方法的最新进展。
AAPS J. 2021 Jan 5;23(1):14. doi: 10.1208/s12248-020-00532-2.
8
Role of monoclonal antibody drugs in the treatment of COVID-19.单克隆抗体药物在新冠病毒疾病治疗中的作用。
World J Clin Cases. 2020 Oct 6;8(19):4280-4285. doi: 10.12998/wjcc.v8.i19.4280.
9
The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19.芦可替尼通过 JAK/STAT 通路抑制在 COVID-19 治疗中的潜力。
Cytokine Growth Factor Rev. 2020 Aug;54:51-62. doi: 10.1016/j.cytogfr.2020.06.013. Epub 2020 Jun 20.
本文引用的文献
1
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病：考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
2
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.基于对来自中国武汉的150名患者数据的分析得出的COVID-19相关死亡的临床预测因素。
Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3.
3
Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial.芦可替尼治疗成人继发性噬血细胞性淋巴组织细胞增生症：一项开放标签、单中心的试点试验。
Lancet Haematol. 2019 Dec;6(12):e630-e637. doi: 10.1016/S2352-3026(19)30156-5. Epub 2019 Sep 16.
4
A journey through infectious risk associated with ruxolitinib.鲁索替尼相关感染风险的探索之旅。
Br J Haematol. 2019 Nov;187(3):286-295. doi: 10.1111/bjh.16174. Epub 2019 Aug 29.
5
Pulmonary Involvement in Patients With Hemophagocytic Lymphohistiocytosis.噬血细胞性淋巴组织细胞增生症患者的肺部受累情况
Chest. 2016 May;149(5):1294-301. doi: 10.1016/j.chest.2015.11.004. Epub 2016 Jan 13.
6
Efficacy and safety of ruxolitinib in the treatment of patients with myelofibrosis.芦可替尼治疗骨髓纤维化患者的疗效和安全性。
Future Oncol. 2015;11(5):719-33. doi: 10.2217/fon.14.272.
7
Reactivation of hepatitis B virus infection following ruxolitinib treatment in a patient with myelofibrosis.鲁索替尼治疗骨髓纤维化患者后乙肝病毒感染再激活
Leukemia. 2014 Jan;28(1):225-7. doi: 10.1038/leu.2013.235. Epub 2013 Aug 9.
Zotero 插件